jain.com

Q2 2026 Revenue

Company: Nebius

Subject kind
product
Statement date
2026-08-12
Current status
verified

The claim, verbatim

Booked $582.3 million in Q2 revenue, up 454% year over year

Source (primary)

Pure-Play AI Cloud vs. Energy-Driven Infrastructure: Nebius Scale Meets IREN Limited's Efficiency - 247wallst.com (-, news_article)
View cached copy (2026-09-10)Live source ↗Archive.org ↗

Quote: “Nebius booked $582.3 million in Q2 revenue, up 454% year over year”

How we checked this

Checked on October 11, 2026. The cited source supports every part of this claim.

The article states Nebius booked $582.3 million in Q2 FY26 revenue, up 454% year over year. That covers both the amount and the growth rate in the claim.

Confirmed in the source:

What we did: Read our cached copy of the publisher (https://247wallst.com/investing/2026/09/09/pure-play-ai-cloud-vs-energy-driven-infrastructure-nebius-scale-meets-iren-limiteds-efficiency/) in full (10,347 characters, retrieved September 10, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms Pure-Play AI Cloud vs. Energy-Driven Infrastructure: Nebius Scale Meets IREN Limited's Efficiency - 247wallst.com

Quote: “Nebius booked $582.3 million in Q2 revenue, up 454% year over year”

View cached copy (2026-09-10)Live source ↗Archive.org ↗

confirms Nebius’s Price Hike Suggests Michael Burry Made a Mistake and Is Shorting the Best Neocloud Stock - Yahoo Finance

Quote: “revenue of $582.3 million, up 454% year over year and 46% sequentially”

View cached copy (2026-09-23)Live source ↗

confirms Nebius Group N.V. (NBIS) Stock News & Articles - 24/7 Wall St.

Quote: “Revenue $582M est $575M +1.3%”

View cached copy (2026-10-03)Live source ↗Archive.org ↗

Record of changes

September 10, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — verified
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.